Rps25 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Rps25 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@doherty2010]
Rps25 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Introduction
Rps25 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes. [@doherty2010]
Gene Overview
RPS25 (Ribosomal Protein S25) is a gene encoding a ribosomal protein that is a component of the 40S small ribosomal subunit. Located at chromosome 17q25.2, RPS25 encodes a 125-amino acid protein that is highly conserved across eukaryotes. RPS25 is one of the ribosomal proteins that has been implicated in Diamond-Blackfan anemia and other ribosomopathies. [@de2023]
Gene Information
Normal Function
RPS25 is a ribosomal protein component of the 40S small ribosomal subunit. It plays essential roles in:
Protein synthesis - RPS25 contributes to the structural integrity of the 40S subunit and participates in translation initiation
Ribosome assembly - RPS25 is required for proper 40S subunit biogenesis
mRNA binding - The protein participates in mRNA binding and scanning during translation initiation
RPS25 is located in the head region of the 40S subunit, near the mRNA entry channel.
Disease Associations
RPS25 mutations have been associated with:
Diamond-Blackfan anemia (DBA) - RPS25 is one of the ribosomal protein genes mutated in DBA, a rare inherited bone marrow failure syndrome
5q- syndrome - A myelodysplastic syndrome with ribosomal protein involvement
Cancer - Altered expression of RPS25 has been reported in various cancers
Molecular Mechanisms
Ribosomal Function
RPS25 contributes to the structure and function of the 40S subunit through:
Interaction with 18S rRNA
Participation in the translation initiation complex
mRNA binding and decoding
Disease Mechanisms
In DBA, ribosomal protein gene mutations lead to:
Ribosome biogenesis defects
p53 activation due to ribosomal stress
Selective impairment of erythropoiesis
Clinical Significance
Diamond-Blackfan Anemia
RPS25-related DBA features include:
Macrocytic anemia
Reticulocytopenia
Possible congenital anomalies
Cancer predisposition
Research Directions
Understanding the tissue-specific effects of ribosomal mutations
Developing targeted therapies for DBA
Exploring the role of RPS25 in cancer biology
Overview
Rps25 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Background
The study of Rps25 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
[Gazda HT, Sheen MR, Vlachos A, et al, Ribosomal protein L5 and L11 mutations are associated with cleft palate and progressive phenotypes in Diamond-Blackfan anemia (2008)](https://doi.org/10.1016/j.ajhg.2008.11.006)
[Doherty L, Sheen MR, Vlachos A, et al, Ribosomal protein genes RPS10 and RPS26 are frequently mutated in Diamond-Blackfan anemia (2010)](https://doi.org/10.1016/j.ajhg.2009.12.015)
[De Keersmaecker K, Sulima SO, Mills GB, Ribosomal mutations and cancer (2023)](https://doi.org/10.1038/s41568-023-00502-8)
[Narla A, Ebert BL, Ribosomal mutations and the pathogenesis of Diamond-Blackfan anemia (2008)](https://doi.org/10.1182/blood-2008-02-140012)
[Vlachos A, Blanc L, Lipton JM, Diamond-Blackfan anemia: a model for the translational approach (2014)](https://doi.org/10.4172/2161-1025.1000121)
[Mills GB, Zhang Y, De Keersmaecker K, Ribosomal proteins as tumor suppressors (2016)](https://doi.org/10.18632/oncotarget.11518)
[Wang W, Nag S, Zhang X, et al, Ribosomal proteins: functions beyond the ribosome (2015)](https://doi.org/10.1093/jmcb/mjv014)